DIAMOND BIOFUND INC Cash Flow Conversion Efficiency
DIAMOND BIOFUND INC cash flow conversion efficiency. Based on the latest financial reports, DIAMOND BIOFUND INC (6901) has a cash flow conversion efficiency ratio of -0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-21.12 Million ≈ $-665.27K USD) by net assets (NT$9.22 Billion ≈ $290.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of DIAMOND BIOFUND INC (2019–2025)
Cash flow conversion efficiency of DIAMOND BIOFUND INC from 2019 to 2025. This chart illustrates how DIAMOND BIOFUND INC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View DIAMOND BIOFUND INC (6901) share price today for real-time trading data and today's change.
DIAMOND BIOFUND INC Cash Flow Conversion Ratio Explained
DIAMOND BIOFUND INC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
DIAMOND BIOFUND INC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DIAMOND BIOFUND INC ranked by their cash flow conversion efficiency. Also see DIAMOND BIOFUND INC market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bank Artos Indonesia Tbk PT
JK:ARTO
|
0.035x |
|
Tibet Aim Pharm Inc
SHE:002826
|
0.104x |
|
Abm Investama Tbk
JK:ABMM
|
0.038x |
|
Nanjing CEC Environmental Protect
SHE:300172
|
-0.029x |
|
YTL Hospitality REIT
KLSE:5109
|
0.012x |
|
Verra Mobility Corp
NASDAQ:VRRM
|
0.255x |
|
Zota Health Care LImited
NSE:ZOTA
|
-0.157x |
|
APAC Opto Electronics
TWO:4908
|
0.029x |
Annual Cash Flow Conversion Efficiency for DIAMOND BIOFUND INC (2019–2025)
The table below shows the annual cash flow conversion efficiency of DIAMOND BIOFUND INC from 2019 to 2025. Review free cash flow generation of DIAMOND BIOFUND INC to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$9.22 Billion ≈ $290.51 Million |
NT$-165.92 Million ≈ $-5.23 Million |
-0.018x | -116.39% |
| 2024-12-31 | NT$10.37 Billion ≈ $326.81 Million |
NT$1.14 Billion ≈ $35.89 Million |
0.110x | +821.33% |
| 2023-12-31 | NT$12.86 Billion ≈ $405.22 Million |
NT$-195.82 Million ≈ $-6.17 Million |
-0.015x | -135.56% |
| 2022-12-31 | NT$11.05 Billion ≈ $348.15 Million |
NT$473.09 Million ≈ $14.90 Million |
0.043x | +248.09% |
| 2021-12-31 | NT$10.39 Billion ≈ $327.41 Million |
NT$-300.42 Million ≈ $-9.46 Million |
-0.029x | -260.45% |
| 2020-12-31 | NT$9.10 Billion ≈ $286.71 Million |
NT$-72.99 Million ≈ $-2.30 Million |
-0.008x | +38.98% |
| 2019-12-31 | NT$3.01 Billion ≈ $94.85 Million |
NT$-39.57 Million ≈ $-1.25 Million |
-0.013x | -- |
About DIAMOND BIOFUND INC
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.